Summary of project PR001215
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001215. The data can be accessed directly via it's Project DOI: 10.21228/M8NQ5X This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Project ID: | PR001215 |
| Project DOI: | doi: 10.21228/M8NQ5X |
| Project Title: | Metabolic Changes in Multiple Myeloma Patients after CFZ treatment |
| Project Type: | MS Untargeted Metabolomics from Human Serum |
| Project Summary: | In this study we aimed to examine the acute metabolomic changes following proteasome inhibition with Carfilzomib within 8h of treatment. |
| Institute: | University of Zurich |
| Department: | Department of Hematology-Oncology. Kantonsspital St. Gallen |
| Laboratory: | Experimental Hematolgy-KSSG |
| Last Name: | Mendez |
| First Name: | Max |
| Address: | Rorschacherstrasse 95, 9007, St. Gallen. |
| Email: | maxmendez@runbox.com |
| Phone: | +41 71 494 10 67 |
Summary of all studies in project PR001215
| Study ID | Study Title | Species | Institute | Analysis(* : Contains Untargted data) | Release Date | Version | Samples | Download(* : Contains raw data) |
|---|---|---|---|---|---|---|---|---|
| ST001925 | MS Untargeted Metabolomics from Human Serum | Homo sapiens | University of Zurich | MS* | 2022-01-02 | 1 | 42 | Uploaded data (3.9M)* |
